These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10938004)

  • 1. On the association of elevated tPA/PAI-1 complex and von Willebrand factor with recurrent myocardial infarction.
    Bounameaux H; Kruithof EK
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1857-9. PubMed ID: 10938004
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
    Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis.
    Wållberg-Jonsson S; Dahlén GH; Nilsson TK; Rånby M; Rantapää-Dahlqvist S
    Clin Rheumatol; 1993 Sep; 12(3):318-24. PubMed ID: 8258230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory evaluation of fibrinolysis in patients with a history of myocardial infarction.
    Chandler WL; Stratton JR
    Am J Clin Pathol; 1994 Aug; 102(2):248-52. PubMed ID: 8042597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years.
    Thøgersen AM; Nilsson TK; Weinehall L; Boman K; Eliasson M; Hallmans G; Jansson JH
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):340-6. PubMed ID: 19357504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue plasminogen activator antigen is strongly associated with myocardial infarction in young women.
    Mannucci PM; Bernardinelli L; Foco L; Galli M; Ribichini F; Tubaro M; Peyvandi F
    J Thromb Haemost; 2005 Feb; 3(2):280-6. PubMed ID: 15670033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand factor, plasminogen activator inhibitor-1 and C-reactive protein are markers of thrombolytic efficacy in acute myocardial infarction.
    Andreotti F; Hackett DR; Haider AW; Roncaglioni MC; Davies GJ; Beacham JL; Kluft C; Maseri A
    Thromb Haemost; 1992 Dec; 68(6):678-82. PubMed ID: 1287882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation.
    Stefanadi E; Tousoulis D; Antoniades C; Katsi V; Bosinakou E; Vavuranakis E; Triantafyllou G; Marinou K; Tsioufis C; Papageorgiou N; Latsios G; Stefanadis C
    Int J Cardiol; 2009 Apr; 133(2):266-8. PubMed ID: 18187214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnesium therapy, fibrinolytic parameters and von Willebrand factor in acute myocardial infarction.
    Thögersen AM; Jansson JH; Wester PO
    Int J Cardiol; 1996 Sep; 56(1):53-9. PubMed ID: 8891805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure--a COMET substudy.
    Boman K; Jansson JH; Nilsson T; Swedberg K; Cleland JG; Poole-Wilson P
    Thromb Res; 2010 Feb; 125(2):e46-50. PubMed ID: 19762071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative measurement of carotid atherosclerosis in relation to levels of von Willebrand factor and fibrinolytic variables in plasma--a 2-year follow-up study.
    Nilsson TK; Spence JD; Nilsson PM; Eliasson M; Jansson JH; Boman K
    J Cardiovasc Risk; 2002 Aug; 9(4):215-21. PubMed ID: 12394330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction.
    Thøgersen AM; Söderberg S; Jansson JH; Dahlén G; Boman K; Nilsson TK; Lindahl B; Weinehall L; Stenlund H; Lundberg V; Johnson O; Ahrén B; Hallmans G
    Eur J Cardiovasc Prev Rehabil; 2004 Feb; 11(1):33-40. PubMed ID: 15167204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early coronary reperfusion blunts the procoagulant response of plasminogen activator inhibitor-1 and von Willebrand factor in acute myocardial infarction.
    Andreotti F; Roncaglioni MC; Hackett DR; Khan MI; Regan T; Haider AW; Davies GJ; Kluft C; Maseri A
    J Am Coll Cardiol; 1990 Dec; 16(7):1553-60. PubMed ID: 2123906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
    Thögersen AM; Jansson JH; Boman K; Nilsson TK; Weinehall L; Huhtasaari F; Hallmans G
    Circulation; 1998 Nov; 98(21):2241-7. PubMed ID: 9826309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved fibrinolysis after one year of treatment with enalapril in men and women with uncomplicated myocardial infarction.
    Boman KO; Jansson JH; Nyhlén KA; Nilsson TK
    Thromb Haemost; 2002 Feb; 87(2):311-6. PubMed ID: 11859853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of tissue-type plasminogen activator by retinoids in rat plasma and tissues.
    Van Bennekum AM; Emeis JJ; Kooistra T; Hendriks HF
    Am J Physiol; 1993 May; 264(5 Pt 2):R931-7. PubMed ID: 8498603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
    Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C
    Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of PAI-1 activity and t-PA antigen are associated with newly diagnosed abnormal glucose regulation in patients with ST-elevation myocardial infarction.
    Knudsen EC; Seljeflot I; Abdelnoor M; Eritsland J; Mangschau A; Müller C; Arnesen H; Andersen GØ
    J Thromb Haemost; 2011 Aug; 9(8):1468-74. PubMed ID: 21624046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of acute-phase levels of haemostatic factors on reperfusion and mortality in patients with acute myocardial infarction treated with streptokinase.
    Nilsson JB; Boman K; Jansson JH; Nilsson T; Näslund U
    J Thromb Thrombolysis; 2008 Dec; 26(3):188-95. PubMed ID: 17721741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.